SR One Capital Management, LLC insider trades
SR One Capital Management, LLC has filed 3 Form 4s with the SEC that we hold, for Zenas BioPharma, Inc. (ZBIO) (10% owner) and ADARx Pharmaceuticals, Inc. (ADRX) (10% owner). Across all of them we count 6 purchases worth $50.0M and 0 sales worth $0 reported on Form 4. In the last 12 months: 2 purchases ($17.1M) and 0 sales ($0). The largest single trade was a purchase of 1,352,942 shares of Zenas BioPharma, Inc. worth $23.0M, dated 2024-09-16. The first filing on our record is dated 2024-09-16 and the latest 2026-09-29.
Zenas BioPharma, Inc. (ZBIO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-09-16 | P, purchase reported on Form 4 | 441,176 | $7.5M | 2024-09-16 |
| 2024-09-16 | P, purchase reported on Form 4 | 1,352,942 | $23.0M | 2024-09-16 |
| 2025-10-09 | P, purchase reported on Form 4 | 63,157 | $1.2M | 2025-10-14 |
| 2025-10-09 | P, purchase reported on Form 4 | 63,158 | $1.2M | 2025-10-14 |
ADARx Pharmaceuticals, Inc. (ADRX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-09-28 | P, purchase reported on Form 4 | 592,593 | $10.1M | 2026-09-29 |
| 2026-09-28 | P, purchase reported on Form 4 | 414,814 | $7.1M | 2026-09-29 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1853723) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms